Two cases of refractory discoid lupus erythematosus successfully treated with topical tocoretinate

Dermatology Online Journal

Volumn 17, Issue 4, 2011, Pages

  Terao, Mika ^a   Matsui, Saki ^a   Katayama, Ichiro ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINUCLEAR ANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; GLUCOCORTICOID; KERATIN; LUPUS ANTICOAGULANT; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SM ANTIBODY; SUNSCREEN; TACROLIMUS; TOCORETINATE; ALPHA TOCOPHEROL; DERMATOLOGICAL AGENT; DRUG DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; RETINOIC ACID;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CELL INFILTRATION; CELL VACUOLE; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ACTIVITY; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; DRUG SENSITIVITY; ERYTHEMA; FEMALE; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; KERATINOCYTE; LOW DRUG DOSE; MONONUCLEAR CELL; PARTIAL THROMBOPLASTIN TIME; PATIENT SATISFACTION; REFRACTORY DISCOID LUPUS ERYTHEMATOSUS; SKIN ATROPHY; SKIN BIOPSY; SKIN PIGMENTATION; SKIN ULCER; TOPICAL TREATMENT; DRUG COMBINATION; LETTER; MALE; PATHOLOGY; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, DISCOID; MALE; PATIENT SATISFACTION; TREATMENT OUTCOME; TRETINOIN; VITAMIN E;

EID: 79960742667     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Cardinali, C., et al., The spectrum of cutaneous manifestations in lupus erythematosus--the Italian experience. Lupus. 2000;9(6):417-23.
2. Fabbri, P., et al., Cutaneous lupus erythematosus: diagnosis and management. Am J Clin Dermatol. 2003;4(7):449-65.
3. Werth, V., Current treatment of cutaneous lupus erythematosus. Dermatol Online J. 2001 Feb;7(1):2.
4. Edwards, K.R. and W.A. Burke, Treatment of localized discoid lupus erythematosus with tazarotene. J Am Acad Dermatol. 1999 Dec;41(6):1049-50.
5. Goyal, S. and H.C. Nousari, Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil. J Am Acad Dermatol. 2001 Jul;45(1):142-4.
6. Kuhn, A., et al., Successful treatment of discoid lupus erythematosus with argon laser. Dermatology. 2000;201(2):175-7.
7. Callen, J.P., Management of skin disease in patients with lupus erythematosus. Best Pract Res Clin Rheumatol. 2002 Apr;16(2):245-64.
8. Drake, L.A., et al., Guidelines of care for cutaneous lupus erythematosus. American Academy of Dermatology. J Am Acad Dermatol. 1996 May;34(5 Pt 1):830-6.
9. Yamada, E., et al., Tocoretinate inhibited the contraction of collagen gel matrices by human dermal fibroblasts with tenascin-C expression. J Dermatol Sci. 1999 Dec;22(1):45-53.
10. Terao, M., et al., Clinical effect of tocoretinate on lichen and macular amyloidosis. J Dermatol. 2011 Feb;38(2):179-84.
11. Mizutani, H., et al., Topical tocoretinate improved hypertrophic scar, skin sclerosis in systemic sclerosis and morphea. J Dermatol. 1999 Jan;26(1):11-7.
12. Darlenski, R., C. Surber, and J.W. Fluhr, Topical retinoids in the management of photodamaged skin: from theory to evidence-based practical approach. Br J Dermatol. 2010 Dec;163(6):1157-65.
13. Jones, D.A., The potential immunomodulatory effects of topical retinoids. Dermatol Online J. 2005 Mar 1;11(1):3.